+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative analysis of the effectiveness and tolerance of chrysanol and myochrysine in patients with rheumatoid arthritis (preliminary report)



Comparative analysis of the effectiveness and tolerance of chrysanol and myochrysine in patients with rheumatoid arthritis (preliminary report)



Terapevticheskii Arkhiv 57(7): 131-136



Fifty patients with a significant rheumatoid arthritis (RA) were treated with gold salts for 6 months to 4 years. Patients with highly active conditions (stages II-III) and with erosive arthritis (stages IIb-IV) prevailed. Extraarticular manifestations were recognized in 76% of the patients. The efficacy of chrisanol given in a dose of 1.5 ml of a 5% solution was compared to that of myocrisin in a dose of 50 mg, i. e. 25 mg metallic gold once a week. The efficacy of the drugs was evaluated from their effects on the disease activity (clinical manifestations of the articular syndrome, ESR, morphological signs of rheumatoid synovitis) and progression (the rate of the development of erosive arthritis in hand and foot joints, the time course of serum RF content, and systemic disease manifestations). These characteristics were examined with the aid of modern ultrasonic and radionuclide research methods. The evaluations were made by the treatment onset and by months 3, 6, 12 and 18 of the treatment. Analysis of the data obtained attests to a high clinical efficacy of both the drugs exhibiting basic activity which is confirmed by a decrease in the degree of the morphological manifestations of synovitis and extraarticular signs of RA, particularly of myocarditis. A method for following up outpatients to prevent grave complications of chrysotherapy is offered.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039614866

Download citation: RISBibTeXText

PMID: 2931846


Related references

Comparative effectiveness of chrysanol and auranofin in rheumatoid arthritis. Terapevticheskii Arkhiv 59(12): 30-33, 1987

Comparative assessment of the effectiveness and tolerance of gold and d penicillamine drugs in rheumatoid arthritis patients report ii their effect on the morphological symptoms of rheumatoid synovitis. Revmatologiya (2): 23-30, 1990

Rheumatoid factors in controlled treatment of rheumatoid arthritis patients with chrysanol. Revmatologiya (3): 19-22, 1985

2 cases of fibrosing alveolitis in patients with rheumatoid arthritis treated with chrysanol. Klinicheskaia Meditsina 68(9): 99, 1990

Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance. Revmatologiia .(1): 8, 1989

Comparative analysis of effectiveness and safety of diclofenac and nimesulide in patients with early rheumatoid arthritis. Klinicheskaia Meditsina 87(10): 62-66, 2009

A comparative evaluation of the treatment results with cyclosporin A, methotrexate and azathioprine in rheumatoid arthritis patients (a preliminary report). Terapevticheskii Arkhiv 65(5): 65-69, 1993

Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry. Rheumatology and Therapy 4(2): 375-389, 2017

Use of chrysanol in rheumatoid arthritis. Vrachebnoe Delo 1983(1): 37-40, 1983

Complications of the treatment of rheumatoid arthritis with chrysanol. Sovetskaia Meditsina 1989(8): 110-113, 1989

Complications when using chrysanol to treat rheumatoid arthritis. Sovetskaya Meditsina (8): 110-113, 1989

Improved tolerance and cost-effectiveness of subcutaneous vs oral methotrexate in rheumatoid arthritis and juvenile rheumatoid arthritis. Arthritis & Rheumatism 41(9 Suppl. ): S75, 1998

A comparative evaluation of the efficacy and tolerance of gold and D-penicillamine preparations in patients with rheumatoid arthritis. II. The effect on the morphological indices of rheumatoid synovitis. Revmatologiia .(2): 23-9; Discussion 29-30, 1990

Modeling and cost-effectiveness analysis of etanercept in adults with rheumatoid arthritis in Japan: a preliminary analysis. Modern Rheumatology 16(2): 77-84, 2006

The use of lidocaine to reduce the pain of myochrysine injections for children with juvenile rheumatoid arthritis. Journal of Rheumatology 13(2): 356-357, 1986